National Directorate of Renal Healthcare • Ministry of Health & Clinical Excellence
Official Directive Ref: KHD-2026-NATL-01
๐Ÿ›๏ธ National Healthcare Strategic Directive

National Strategic Blueprint for Kidney Health, Dialysis Reduction & Transplantation Excellence

A transformative nationwide framework shifting clinical practice from late-stage dialysis dependence toward proactive renal preservation, pre-emptive living transplantation, and scientific lifestyle rehabilitation.

Evidence Base: Kidney Disease Clinic
Execution Timeline: Immediate National Mandate
Scope: Primary Care, Nephrology Centers & Transplant Units
Annual ESRD Growth Challenge
>500+
Incident hemodialysis starts documented in regional registry cohorts. Urgent need to halt influx.
View Registry Data →
Current Transplant Transition
< 5.5%
Only ~28 of 535 patients access life-saving transplantation. Target is a 5-fold national expansion.
Transplant Protocols →
Dialysis Physiological Reality
50%+
Long-term mortality on dialysis due to uremic toxins and cardiovascular stress dialysis cannot clear.
Dialysis Limitations →
Strategic Pillar I

Minimizing Incident Dialysis Patients Every Year

Preventing kidney failure progression through early detection, aggressive etiologic treatment, nephrotoxin eradication, and delayed incremental starts.

โšก Executive Directive: Progression Interception Mandate

  • All primary care networks must compute the KFRE score on patients with eGFR < 45 mL/min/1.73m². Scores > 5% trigger fast-track nephrology co-management.
  • Hospital EHRs must enforce hard-stop alerts against nephrotoxic synergies (NSAID + ACEi/ARB + Diuretic).
Strategic Pillar II

Exponentially Increasing Kidney Transplantation

Establishing pre-emptive transplantation as the first-line standard of care, expanding living donor paired swaps, and eradicating alloimmunization barriers.

โšก Executive Directive: Transplant-First National Mandate

  • Every patient with CKD Stage 4 must be referred for pre-emptive transplant evaluation within 30 days of reaching eGFR < 20 mL/min.
  • Establish a zero-avoidable-transfusion policy across all renal units to prevent HLA sensitization.
Strategic Pillar III

Improving Lifestyle, Longevity & Quality of Life

Scientific dietary autonomy, cardiovascular protection, ultrafiltration safety, fistula preservation, advanced dialysis, and psychosocial support.

โšก Executive Directive: Dialysis Quality & Patient Safety Mandate

  • All hemodialysis prescriptions must strictly enforce UFR limits < 12 mL/kg/h as mandated in HD-CL-006-F4.
  • Units must achieve ≥ 80% permanent arteriovenous access and < 10% central venous catheters within 12 months.
Governance & Audits

National Performance Accountability Matrix

Quarterly clinical benchmarks mandated across all regional health networks and dialysis facilities.

Pillar National Performance Indicator (KPI) Target Benchmark Clinical Reference & Policy Link
Pillar 1: Delay KFRE Risk Assessment completed in CKD Stage 3โ€“5 ≥ 90% Eligible Cohort KFRE Calculator →
Pillar 1: Delay Guideline-Directed Medical Therapy in Diabetic CKD ≥ 85% Eligible Cohort Diabetic Nephropathy →
Pillar 1: Delay Evaluation for Incremental Dialysis in incident patients 100% Incident Patients Incremental Dialysis →
Pillar 2: Transplant Pre-emptive Listing rate for patients with eGFR < 20 ≥ 50% Incident ESKD Kidney Transplant →
Pillar 2: Transplant Sensitization Prevention (Avoidable Blood Transfusions) < 5% While on Waitlist Anemia Analysis →
Pillar 3: Lifestyle Permanent Vascular Access Rate (AVF/AVG vs CVC) > 80% AVF / < 10% CVC Vascular Access HD-CL-001 →
Pillar 3: Lifestyle Ultrafiltration Rate Safety Adherence (< 12 mL/kg/h) ≥ 95% of Dialysis Runs UFR Policy HD-CL-006-F4 →
Pillar 3: Lifestyle Adequacy Compliance (spKt/V ≥ 1.2 or URR ≥ 65%) ≥ 90% Maintenance Cohort Kt/V Calculator →